Ganih, Alice .

HRN: 21-69-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2022
CEFUROXIME 1.5GM (VIAL)
07/31/2022
07/31/2022
IV
1.5gm
Prior OR
Prophylaxis For OR Elective Polypectomy With Fractional Curettage
Waiting Final Action 
08/01/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/01/2022
08/08/2022
IV
625mg
BID
SP Punch Biopsy; SP Elective Polypectomy
Waiting Final Action 
08/01/2022
CO-AMOXICLAV 625MG (TAB)
08/01/2022
08/08/2022
ORAL
625mg
BID
SP Punch Biopsy; SP Elective Polypectomy
Waiting Final Action 
10/21/2022
CEFUROXIME 1.5GM (VIAL)
10/22/2022
10/22/2022
IV
1.5gm
30 Mins Prior OR
Pre-OP Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: